Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

LLENZ THERAPEUTICS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
L

LENZ THERAPEUTICS, INC.

$4.13Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $5.49M. Net result −$31.92M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $5.49M. Running result $5.49M. License: $3.75M. Product: $1.74M.
  • Cost of revenue: −$280K. Running result $5.21M.
  • Gross profit: $5.21M. Running result $5.21M.
  • Selling, general and administrative: −$39.38M. Running result −$34.17M.
  • Research and development: $0. Running result −$34.17M.
  • Operating income: −$34.17M. Running result −$34.17M.
  • Other income: $2.26M. Running result −$31.92M.
  • Pre-tax loss: −$31.92M. Running result −$31.92M.
  • Income tax expense: −$3K. Running result −$31.92M.
  • Net loss: −$31.92M. Running result −$31.92M.